SCHEMBL4116754

SCHEMBL4116754

O=C(O)C1c2ccccc2C2(CCNCC2)CN1C(=O)O

nearest known ligand 0.35

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ACE P12821 5/20 0.35
CYP1A2 P05177 3/20 0.35
CYP3A4 P08684 2/20 0.35
CYP2D6 P10635 2/20 0.35
USP2 O75604 1/20 0.35
CYP2C9 P11712 1/20 0.35
NOTUM Q6P988 2/20 0.34
TSHR P16473 1/20 0.34
P2RY1 P47900 1/20 0.34
ROCK2 O75116 1/20 0.33
ROCK1 Q13464 1/20 0.33
HSD11B1 P28845 1/20 0.33
DPP9 Q86TI2 1/20 0.33
DPP7 Q9UHL4 1/20 0.33
AKT1 P31749 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3994423 0.81 DPP9 (0.35) CYP1A2CYP3A4CYP2D6USP2CYP2C9
SCHEMBL4118605 0.80 HSD11B1 (0.47) HSD11B1
SCHEMBL4124959 0.80 HSD11B1 (0.39) P2RY1ROCK2ROCK1HSD11B1
Hydrochloric Acid SCHEMBL1747690 0.80 NOTUM (0.34) CYP1A2CYP3A4CYP2D6USP2CYP2C9
SCHEMBL1222859 0.73 HSD11B1 (0.51) CYP1A2CYP2D6TSHRHSD11B1DPP9
SCHEMBL5599306 0.72 USP2 (0.33) CYP1A2CYP3A4CYP2D6USP2CYP2C9
SCHEMBL5281455 0.71 SMN1; SMN2 (0.44) CYP1A2CYP3A4CYP2D6USP2CYP2C9
SCHEMBL1572534 0.71 NOTUM (0.63) NOTUMP2RY1ROCK2ROCK1AKT1
SCHEMBL30232786 0.71 NOTUM (0.63) NOTUMP2RY1ROCK2ROCK1AKT1
SCHEMBL653997 0.69 DPP9 (0.50) CYP1A2CYP3A4CYP2D6NOTUMTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2064187-A2 INHIBITORS OF 11BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 Vitae Pharmaceuticals, Inc. (US) 2009-06-03 EP claimed
WO-2008024497-A2 INHIBITORS OF 11β -HYDROXYSTEROID DEHYDROGENASE TYPE 1 VITAE PHARMACEUTICALS, INC. (US) 2008-02-28 WO claimed